로딩 중…
지수 로딩 중…
OSTEONIC Co., Ltd.
226400· KOSDAQ· Health Care· Health Care Equipment & Services
₩4,265+0.83%
2026-09-18
Financials
Valuation Metrics
OSTEONIC Co., Ltd.'s Market Cap is ₩881B. At end of 2025 it was ₩1285B. Ranked #1354 of 2,421 in KR market (top 56%), #757 of 1,640 on KOSDAQ (top 46%), #50 of 96 in Health Care Equipment & Services (top 52%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 88.12B KRW | KR#1,354/2,421 Sec#50/96 |
| Revenue | 50.97B KRW | KR#1,780/2,421 Sec#52/96 |
| Net Income | 10.20B KRW | KR#966/2,421 Sec#25/96 |
| Total Assets | 113.71B KRW | KR#1,678/2,421 Sec#50/96 |
| Net Assets | 72.05B KRW | KR#1,665/2,421 Sec#51/96 |
| Employees | 179 | KR#1,173/2,421 Sec#35/96 |
| Value | ||
| P/E | 8.64x | KR#710/2,421 Sec#21/96 |
| P/B | 1.22x | KR#1,635/2,421 Sec#54/96 |
| PEG | 0.11x | KR#430/2,421 Sec#20/96 |
| P/S | 1.73x | KR#1,719/2,421 Sec#46/96 |
| EV/EBITDA | 9.93x | KR#614/2,421 Sec#20/96 |
| FCF Yield | 0.37% | KR#1,185/2,421 Sec#32/96 |
| Profitability | ||
| ROE | 14.16% | KR#361/2,421 Sec#12/96 |
| ROA | 8.97% | KR#347/2,421 Sec#18/96 |
| Op. Margin | 18.38% | KR#195/2,421 Sec#17/96 |
| Revenue Growth | 32.74% | KR#356/2,421 Sec#18/96 |
| Earnings Growth | 77.20% | KR#443/2,421 Sec#22/96 |
| Financial Health | ||
| Debt Ratio | 57.82% | KR#1,068/2,421 Sec#60/96 |
| Total Debt | 19.26B KRW | KR#1,391/2,421 Sec#41/96 |
| FCF | 323.6M KRW | KR#1,201/2,421 Sec#33/96 |
| Cash | 14.29B KRW | KR#1,463/2,421 Sec#43/96 |
| Current Ratio | 2.27x | KR#766/2,421 Sec#44/96 |
| Net Debt/EBITDA | 0.53x | KR#679/2,421 Sec#28/96 |
| Performance | ||
| 1Y Return | -46.55% | KR#1,979/2,421 Sec#66/96 |
| 1M Return | 0.95% | KR#1,121/2,421 Sec#32/96 |
| From 52W High | -47.86% | KR#1,286/2,421 Sec#40/96 |
| 1Y MDD | -53.99% | KR#1,170/2,421 Sec#40/96 |
| Trading | ||
| Volume | 107,966 shares | KR#747/2,421 Sec#25/96 |
| Trading Value | 458.8M KRW | KR#956/2,421 Sec#30/96 |
| Foreign Own. | 6.26% | KR#705/2,421 Sec#20/96 |
| Per Share | ||
| EPS | 494 KRW | KR#1,002/2,421 Sec#26/96 |
| BPS | 3,487 KRW | KR#1,757/2,421 Sec#48/96 |
Company Info
Osteonick, established in 2012, specializes in the development, manufacturing, and sale of orthopedic implants, and was listed on KOSDAQ in 2018. The company produces metal and biomaterial-based implants across all orthopedic fields, supplying medical devices for the fixation, replacement, and adjustment of fractured bones. It has secured vertically integrated process technology, collaborates with B. Braun, and is pursuing FDA and CE approvals to expand into global markets. Osteonick is headquartered in Guro-gu, Seoul.